ROSEMARY MAZANET
CIK 1276892 · Chief Scientific Officer · last filed 2025-04-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
37
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics, Inc. (ONCT) Delisted | Director | — | $0.53 | — | $0 | 6 | 2024-06-24 |
| SELLAS Life Sciences Group, Inc. (GALE) Delisted | Chief Medical Officer | — | — | — | $0 | 2 | 2013-01-31 |
| Oncternal Therapeutics, Inc. (GTXI) Delisted | Director | 22,781 | — | — | $0 | 12 | 2009-05-11 |
Recent Filings · Page 3 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-28 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-05-22 | — | Buy (P) | +100 | $395 | |
| 2013-01-31 | SELLAS Life Sciences Group, Inc. (GALE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-06-19 | SELLAS Life Sciences Group, Inc. (GALE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-05-11 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-01-05 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | +89 | $1.5K | EDGAR |
| 2008-10-02 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | +381 | $7.2K | EDGAR |
| 2008-07-02 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | +505 | $7.2K | EDGAR |
| 2008-05-05 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-04-02 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | +497 | $8.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.